DiaMedica Therapeutics
- Pharmaceutical Preparations
- Minneapolis, Minnesota
Compensation history
Top executives at DiaMedica Therapeutics received an average of $715K per person in annual compensation from 2017 to 2023.
By year
Executives
We found six executives who work or worked at DiaMedica Therapeutics.
Rick Pauls
DiaMedica Therapeutics
Chief Executive Officer
Scott Kellen
DiaMedica Therapeutics
Chief Financial Officer
Julie Daves
DiaMedica Therapeutics
SVP, Clinical Development Operations
Kirsten Gruis
DiaMedica Therapeutics
Chief Medical Officer
Harry Alcorn
DiaMedica Therapeutics
Senior Vice President of Clinical Operations
Todd Verdoorn
DiaMedica Therapeutics
Chief Scientific Officer
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019
About DiaMedica Therapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 301 Carlson Parkway, Suite 210, Minneapolis, Minnesota 55305
- (763) 496-5454
- December 31
- Former names
- DiaMedica Inc.